Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-26-022154
Filing Date
2026-05-11
Accepted
2026-05-11 09:00:49
Documents
58
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 855347
2 EX-31.1 ex31-1.htm EX-31.1 16698
3 EX-31.2 ex31-2.htm EX-31.2 16713
4 EX-32.1 ex32-1.htm EX-32.1 7422
5 EX-32.2 ex32-2.htm EX-32.2 7816
  Complete submission text file 0001493152-26-022154.txt   5174698

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE maia-20260331.xsd EX-101.SCH 38333
7 XBRL CALCULATION FILE maia-20260331_cal.xml EX-101.CAL 40245
8 XBRL DEFINITION FILE maia-20260331_def.xml EX-101.DEF 159316
9 XBRL LABEL FILE maia-20260331_lab.xml EX-101.LAB 360218
10 XBRL PRESENTATION FILE maia-20260331_pre.xml EX-101.PRE 288294
61 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 752151
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41455 | Film No.: 26961103
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)